Kurian Thott
Obstetrics & Gynecology · Stafford, VANPI 1508074857
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $168,447 of the $216,089 with a category attached, or 78.0%. 36 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.7% of the total. 2025 is the largest year on record at $80,409, more than ten times the $6,813 reported in 2019. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $690.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$107K
- Johnson & Johnson$62K
- Intuitive Surgical$22K
- Ethicon Endo-surgery Inc.$18K
- Mimedx Group, Inc.$4K
- Momentis Surgical Inc.$851
- plus $2K from 30 others
What the payments were for
- Consulting fees$168,44778%
- Speaking & faculty fees$3,5002%
- Travel & lodging$25,38912%
- Food & beverage$6,0163%
- Education$12,7076%
- Gifts$90%
- Entertainment$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 98 | $107,337 |
| Johnson & Johnson(2 entities) | 47 | $61,783 |
| Intuitive Surgical | 61 | $22,164 |
| Ethicon Endo-surgery Inc. | 4 | $17,550 |
| Mimedx Group, Inc. | 1 | $4,098 |
| Momentis Surgical Inc. | 2 | $851 |
| AbbVie(2 entities) | 13 | $362 |
| Caldera Medical, Inc | 2 | $255 |
| Sumitomo Pharma America, Inc. | 9 | $227 |
| Pfizer | 12 | $184 |
| Axonics, Inc. | 12 | $178 |
| Boston Scientific | 5 | $140 |
| Merck | 7 | $117 |
| Organon | 4 | $94 |
| Myovant Sciences Inc. | 3 | $68 |
| Therapeuticsmd, Inc. | 4 | $67 |
| Coloplast | 3 | $63 |
| Duchesnay USA Incorporated | 2 | $48 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Bayer | 2 | $41 |
| Pacira Pharmaceuticals Incorporated | 2 | $35 |
| Coopersurgical, Inc. | 1 | $34 |
| Exeltis, USA Inc. | 2 | $32 |
| Urovant Sciences Inc | 1 | $28 |
| Valencia Technologies Corporation | 1 | $27 |
| Lupin Inc. | 2 | $27 |
| Optumhealth Care Solutions, LLC | 1 | $25 |
| Femselect Inc. | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Provepharm Inc. | 1 | $23 |
| Millicent US Inc | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Minerva Surgical, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Harmonic$77,466
- Enseal$76,362
- STRATAFIX$47,021
- ETHICON$44,021
- Enseal X1$43,430
- Da Vinci Surgical System$19,846
- HARMONIC Product Family$8,438
- DAVINCI XI$1,500
- SURGICEL Family of Absorbable Hemostats$1,313
- Anovo Surgical System$851
- EVICEL Fibrin Sealant (Human)$563
- SURGIFLO Hemostatic Matrix Family of Products$563
- SURGICEL NU-KNIT$491
- Desara$255
- Orilissa$125
- VISTASEAL$116
How this compares
$216,089 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 11 | $10,899 |
| Estradiol | 70 | $3,661 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $227 | $10,89911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Stafford
- Yetunde AdenleStafford$6K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- Bunan AlnaifChesapeake$139K
- James JonesRichmond$134K
- Melissa DelgadoVienna$95K
- Joann PinkertonCharlottesville$35K
- Kristin SchraaMechanicsville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.